These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 36637699)
21. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro. Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579 [TBL] [Abstract][Full Text] [Related]
22. Anti-α-synuclein Toxicity and Anti-neurodegenerative Role of Chrysin in Transgenic Muhammad F; Liu Y; Wang N; Zhao L; Zhou Y; Yang H; Li H ACS Chem Neurosci; 2022 Feb; 13(4):442-453. PubMed ID: 35118868 [TBL] [Abstract][Full Text] [Related]
24. Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans. Cheon SM; Jang I; Lee MH; Kim DK; Jeon H; Cha DS Pharm Biol; 2017 Dec; 55(1):481-486. PubMed ID: 27937005 [TBL] [Abstract][Full Text] [Related]
25. Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model. Yan J; Yang Z; Zhao N; Li Z; Cao X BMC Neurosci; 2019 Jun; 20(1):31. PubMed ID: 31208386 [TBL] [Abstract][Full Text] [Related]
26. Neuroprotective Effects of Betulin in Pharmacological and Transgenic Caenorhabditis elegans Models of Parkinson's Disease. Tsai CW; Tsai RT; Liu SP; Chen CS; Tsai MC; Chien SH; Hung HS; Lin SZ; Shyu WC; Fu RH Cell Transplant; 2017 Dec; 26(12):1903-1918. PubMed ID: 29390878 [TBL] [Abstract][Full Text] [Related]
27. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes. Berkowitz LA; Hamamichi S; Knight AL; Harrington AJ; Caldwell GA; Caldwell KA J Vis Exp; 2008 Jul; (17):. PubMed ID: 19066512 [TBL] [Abstract][Full Text] [Related]
28. Aureusidin ameliorates 6-OHDA-induced neurotoxicity via activating Nrf2/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway in SH-SY5Y cells and Caenorhabditis elegans. Hu K; Zhu S; Wu F; Zhang Y; Li M; Yuan L; Huang W; Zhang Y; Wang J; Ren J; Yang H Chem Biol Interact; 2024 Jan; 387():110824. PubMed ID: 38056806 [TBL] [Abstract][Full Text] [Related]
29. Alpha-Mangostin Alleviates the Short-term 6-Hydroxydopamine-Induced Neurotoxicity and Oxidative Damage in Rat Cortical Slices and in Caenorhabditis elegans. Estrada-Valencia R; Hurtado-Díaz ME; Rangel-López E; Retana-Márquez S; Túnez I; Tinkov A; Karasu C; Ferrer B; Pedraza-Chaverri J; Aschner M; Santamaría A Neurotox Res; 2022 Apr; 40(2):573-584. PubMed ID: 35380367 [TBL] [Abstract][Full Text] [Related]
30. Osmotic stress induced toxicity exacerbates Parkinson's associated effects via dysregulation of autophagy in transgenic C. elegans model. Jadiya P; Mir SS; Nazir A Cell Signal; 2018 May; 45():71-80. PubMed ID: 29410282 [TBL] [Abstract][Full Text] [Related]
31. Sesquiterpenoids isolated from davana (Artemisia pallens Wall. ex DC) mitigates parkinsonism in Caenorhabditis elegans disease model. Trivedi M; Singh S; Pandey T; Gupta SK; Verma RS; Pandey R Biochem Biophys Res Commun; 2022 Jun; 609():15-22. PubMed ID: 35413535 [TBL] [Abstract][Full Text] [Related]
32. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease. Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146 [TBL] [Abstract][Full Text] [Related]
33. Studying Parkinson's disease using Caenorhabditis elegans models in microfluidic devices. Youssef K; Tandon A; Rezai P Integr Biol (Camb); 2019 May; 11(5):186-207. PubMed ID: 31251339 [TBL] [Abstract][Full Text] [Related]
34. The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans. Bornhorst J; Chakraborty S; Meyer S; Lohren H; Brinkhaus SG; Knight AL; Caldwell KA; Caldwell GA; Karst U; Schwerdtle T; Bowman A; Aschner M Metallomics; 2014 Mar; 6(3):476-90. PubMed ID: 24452053 [TBL] [Abstract][Full Text] [Related]
35. A Systematic RNAi Screen of Neuroprotective Genes Identifies Novel Modulators of Alpha-Synuclein-Associated Effects in Transgenic Caenorhabditis elegans. Jadiya P; Fatima S; Baghel T; Mir SS; Nazir A Mol Neurobiol; 2016 Nov; 53(9):6288-6300. PubMed ID: 26567108 [TBL] [Abstract][Full Text] [Related]
36. Exploring Caenorhabditis elegans as Parkinson's Disease Model: Neurotoxins and Genetic Implications. da Silva LPD; da Cruz Guedes E; Fernandes ICO; Pedroza LAL; da Silva Pereira GJ; Gubert P Neurotox Res; 2024 Feb; 42(1):11. PubMed ID: 38319410 [TBL] [Abstract][Full Text] [Related]
37. Autophagy and UPS pathway contribute to nicotine-induced protection effect in Parkinson's disease. Ullah I; Uddin S; Zhao L; Wang X; Li H Exp Brain Res; 2024 Apr; 242(4):971-986. PubMed ID: 38430248 [TBL] [Abstract][Full Text] [Related]
39. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646 [TBL] [Abstract][Full Text] [Related]
40. Cannabidivarin alleviates α-synuclein aggregation via DAF-16 in Caenorhabditis elegans. Wang F; Jin T; Li H; Long H; Liu Y; Jin S; Lu Y; Peng Y; Liu C; Zhao L; Wang X FASEB J; 2023 Feb; 37(2):e22735. PubMed ID: 36583706 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]